[Adrenergic blocking agents. A chemical review]. 1966

B Danielsson

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

B Danielsson
January 1968, Canadian Anaesthetists' Society journal,
B Danielsson
September 1985, The Mount Sinai journal of medicine, New York,
B Danielsson
June 1983, Journal of clinical and hospital pharmacy,
B Danielsson
January 1974, Clinical anesthesia,
B Danielsson
October 1947, American professional pharmacist,
B Danielsson
January 1978, International anesthesiology clinics,
B Danielsson
January 1982, Journal of emergency nursing,
B Danielsson
September 1982, Midwife, health visitor & community nurse,
B Danielsson
March 1967, The New England journal of medicine,
Copied contents to your clipboard!